Marsden J R, Shuster S, Dennis J D
Hum Toxicol. 1985 May;4(3):335-8. doi: 10.1177/096032718500400317.
Eight male subjects aged 18-24 years were treated with 0.5 mg of isotretinoin day-1 kg-1. After 4 weeks levels of cholesterol (P less than 0.05) and triglyceride (P less than 0.05) were increased and levels of high-density lipoprotein (HDL)-cholesterol were decreased (P less than 0.05). Concentrations of aspartate aminotransferase (P less than 0.01) and gamma-glutamyltranspeptidase (P less than 0.01) were higher after treatment; increased alkaline phosphatase and a reduction in bilirubin levels did not reach statistical significance. Values for thyroxine were reduced after isotretinoin and free thyroxine index was lower (P less than 0.01). Measurements of salivary clearance of antipyrine and levels of alpha 1-acid glycoprotein were lower after treatment but these differences did not reach statistical significance. The findings suggest that there is a small decrease in hepatic microsomal-enzyme activity after isotretinoin and that the unwanted effects on lipids, liver and thyroid function are unlikely to be due to hepatic microsomal-enzyme induction.
8名年龄在18至24岁的男性受试者接受了每日每千克体重0.5毫克异维A酸的治疗。4周后,胆固醇水平(P<0.05)和甘油三酯水平(P<0.05)升高,高密度脂蛋白(HDL)胆固醇水平降低(P<0.05)。治疗后,天冬氨酸转氨酶浓度(P<0.01)和γ-谷氨酰转肽酶浓度(P<0.01)升高;碱性磷酸酶升高和胆红素水平降低未达到统计学显著性。异维A酸治疗后甲状腺素值降低,游离甲状腺素指数较低(P<0.01)。治疗后安替比林唾液清除率测量值和α1-酸性糖蛋白水平较低,但这些差异未达到统计学显著性。研究结果表明,异维A酸治疗后肝微粒体酶活性有小幅下降,对脂质、肝脏和甲状腺功能的不良影响不太可能是由于肝微粒体酶诱导所致。